# OnCo record verdinexor (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/verdinexor/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "verdinexor" ;
  schema:name "Verdinexor"@en ;
  schema:alternateName "Laverdia"@en, "KPT-335"@en, "verdinexor tablets"@en, "Laverdia" ;
  schema:description "Verdinexor (Laverdia) is a tablet for dogs with lymphoma, the first oral lymphoma treatment for dogs to gain full approval from the US Food and Drug Administration. It works the same way as the human myeloma drug selinexor."@en ;
  schema:url <https://onco.cc/drugs/verdinexor/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.fda.gov/consumers/consumer-updates/my-dog-has-cancer-what-do-i-need-know>, <https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17795>, <https://www.fda.gov/animal-veterinary/cvm-updates/fda-grants-full-approval-first-oral-treatment-lymphoma-dogs>, <https://doi.org/10.1186/s12917-018-1587-9> ;
  onco:tag "veterinary", "comparative-oncology" ;
  onco:modality "small molecule (selective inhibitor of nuclear export)" ;
  onco:related <https://onco.cc/ideas/idea-bio1-comparative-oncology-dogs/>, <https://onco.cc/journals/veterinary-and-comparative-oncology/>, <https://onco.cc/drugs/selinexor/> ;
  onco:targets <https://onco.cc/targets/xpo1/> .